Race against time: new drug aims to save brains up to a day after stroke
NCT ID NCT07201688
Summary
This large Phase 3 trial is testing whether a new clot-dissolving drug (rhTNK-tPA) can help people recover better from a major stroke, even if treatment starts up to 24 hours after symptoms begin. It will enroll about 890 adults who have a blocked brain artery and specific brain scan findings. Participants are randomly assigned to receive either the active drug or a placebo, and their recovery and independence are measured 90 days later.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Puyang Oilfield General Hospital
RECRUITINGPuyang, Henan, 457001, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.